This inventor holds 1 USPTO granted patent. Top assignee: The University of British Columbia. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Masafumi Kumano: Innovator in Cancer Therapy
Introduction
Masafumi Kumano is a prominent inventor based in Kobe, Japan. He has made significant contributions to the field of cancer therapy through his innovative research and development. His work focuses on combining various therapeutic approaches to enhance treatment efficacy.
Latest Patents
Masafumi Kumano holds a patent for a groundbreaking combination therapy for cancer. This therapy utilizes HSP27 inhibitors alongside EGFR tyrosine kinase inhibitors or anti-folates. The patent highlights the potential of this combination to improve cancer treatment outcomes.
Career Highlights
Kumano's career is marked by his dedication to advancing cancer research. He is affiliated with the University of British Columbia, where he continues to explore innovative solutions for cancer treatment. His work has garnered attention for its potential to change the landscape of cancer therapies.
Collaborations
Masafumi Kumano has collaborated with notable researchers in the field, including Martin E. Gleave and Amina Zoubeidi. These collaborations have enriched his research and contributed to the development of effective cancer therapies.
Conclusion
Masafumi Kumano's contributions to cancer therapy through his innovative patent and collaborative efforts underscore his role as a leading inventor in the field. His work continues to inspire advancements in cancer treatment strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile